VERACYTE INC (VCYT) Stock Fundamental Analysis

NASDAQ:VCYT • US92337F1075

35.93 USD
-0.06 (-0.17%)
Last: Feb 12, 2026, 09:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall VCYT gets a fundamental rating of 6 out of 10. We evaluated VCYT against 523 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make VCYT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year VCYT was profitable.
  • VCYT had a positive operating cash flow in the past year.
  • In the past 5 years VCYT reported 4 times negative net income.
  • In multiple years VCYT reported negative operating cash flow during the last 5 years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of VCYT (2.22%) is better than 89.10% of its industry peers.
  • The Return On Equity of VCYT (2.41%) is better than 90.06% of its industry peers.
  • VCYT's Return On Invested Capital of 2.93% is amongst the best of the industry. VCYT outperforms 90.06% of its industry peers.
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROIC 2.93%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Profit Margin value of 6.12%, VCYT belongs to the best of the industry, outperforming 89.87% of the companies in the same industry.
  • VCYT has a Operating Margin of 9.70%. This is amongst the best in the industry. VCYT outperforms 91.59% of its industry peers.
  • Looking at the Gross Margin, with a value of 68.53%, VCYT belongs to the top of the industry, outperforming 81.07% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
Industry RankSector Rank
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
  • Compared to 1 year ago, VCYT has more shares outstanding
  • The number of shares outstanding for VCYT has been increased compared to 5 years ago.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 15.88 indicates that VCYT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 15.88, VCYT belongs to the best of the industry, outperforming 86.81% of the companies in the same industry.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.88
ROIC/WACC0.24
WACC12.37%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT's Current ratio of 6.23 is fine compared to the rest of the industry. VCYT outperforms 63.67% of its industry peers.
  • VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT's Quick ratio of 5.94 is fine compared to the rest of the industry. VCYT outperforms 63.10% of its industry peers.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.94
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 353.33% over the past year.
  • The Revenue has grown by 16.41% in the past year. This is quite good.
  • Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 51.21% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 11.52% on average per year.
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • VCYT is valuated quite expensively with a Price/Earnings ratio of 94.55.
  • Based on the Price/Earnings ratio, VCYT is valued cheaper than 89.67% of the companies in the same industry.
  • VCYT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.18.
  • The Price/Forward Earnings ratio is 31.80, which means the current valuation is very expensive for VCYT.
  • Based on the Price/Forward Earnings ratio, VCYT is valued cheaper than 91.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, VCYT is valued at the same level.
Industry RankSector Rank
PE 94.55
Fwd PE 31.8
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaper than 91.97% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaper than 93.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.99
EV/EBITDA 34.62
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of VCYT may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 63.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.2
PEG (5Y)N/A
EPS Next 2Y94.08%
EPS Next 3Y63.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VCYT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERACYTE INC

NASDAQ:VCYT (2/12/2026, 9:35:00 AM)

35.93

-0.06 (-0.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)02-25
Inst Owners114.83%
Inst Owner Change-2.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.84B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (38.32%)
Short Float %6.58%
Short Ratio6.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)15.74%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)12.59%
EPS NY rev (1m)1.2%
EPS NY rev (3m)34.36%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 94.55
Fwd PE 31.8
P/S 5.74
P/FCF 28.99
P/OCF 26.37
P/B 2.26
P/tB 7.14
EV/EBITDA 34.62
EPS(TTM)0.38
EY1.06%
EPS(NY)1.13
Fwd EY3.15%
FCF(TTM)1.24
FCFY3.45%
OCF(TTM)1.36
OCFY3.79%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.2
PEG (5Y)N/A
Graham Number11.66
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 2.41%
ROCE 3.71%
ROIC 2.93%
ROICexc 4.08%
ROICexgc 54.52%
OM 9.7%
PM (TTM) 6.12%
GM 68.53%
FCFM 19.79%
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.07%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 153.6%
Profit Quality 323.21%
Current Ratio 6.23
Quick Ratio 5.94
Altman-Z 15.88
F-Score8
WACC12.37%
ROIC/WACC0.24
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y78.93%
EPS Next 2Y94.08%
EPS Next 3Y63.11%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year15.05%
Revenue Next 2Y13.16%
Revenue Next 3Y12.77%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year320.9%
EBIT Next 3Y74.34%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 6 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 94.55 and the Price/Book (PB) ratio is 2.26.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.